January 31, 2017 Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team
January 31, 2017 Accelerating drug development for Alzheimer’s disease through the use of data standards
January 12, 2017 Patient-Reported Outcome (PRO) Consortium Translation Process: Consensus Development of Updated Best Practices
January 12, 2017 Emerging Good Practices for Translatability Assessment (TA) of Patient-Reported Outcome (PRO) Measures
January 12, 2017 A Standardised Method for Interpreting the Association Between Mutations and Phenotypic Drug Resistance in Mycobacterium Tuberculosis
January 5, 2017 Tuberculosis and Antimicrobial Resistance – New Models of Research and Development Needed
January 3, 2017 Removing the Bottleneck in Whole Genome Sequencing of Mycobacterium Tuberculosis for Rapid Drug Resistance Analysis: A Call to Action
